Patents by Inventor T. Keith Blackwell

T. Keith Blackwell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHASE II DETOXIFICATION AND ANTIOXIDANT ACTIVITY
    Publication number: 20110091587
    Abstract: Provided are methods and compositions that enhance Nrf2 (SKN-1) activation of phase II detoxification or antioxidant enzyme transcription, comprising plant extracts (e.g., willow extracts) or active fractions thereof, as well as methods for identifying additional compounds that increase the Nrf2-regulation of those enzymes.
    Type: Application
    Filed: September 11, 2008
    Publication date: April 21, 2011
    Applicants: JOSLIN DIABETES CENTER, INC., SUNSTAR INC.
    Inventors: T. Keith Blackwell, Motonobu Matsumoto, Taketoshi Makino, Masashi Goto, Atsushi Ishikado, Mariko Maeda, Satoe Azechi
  • SKN-1 and GSK-3 genes and proteins
    Patent number: 7572949
    Abstract: The present invention relates, in part, to the C. elegans SKN-1 gene and protein (a transcription factor), and target genes thereof. The invention includes various therapeutic methods and screening methods for identifying antioxidants.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: August 11, 2009
    Assignee: Immune Disease Institute, Inc.
    Inventors: T. Keith Blackwell, Jae Hyung An
  • Skn-1 and Gsk-3 Genes and Proteins
    Publication number: 20080141385
    Abstract: The present invention relates, in part, to the C. elegans SKN-1 gene and protein (a transcription factor), and target genes thereof. The invention includes various therapeutic methods and screening methods for identifying antioxidants.
    Type: Application
    Filed: June 14, 2004
    Publication date: June 12, 2008
    Inventors: T. Keith Blackwell, Jae Hyung An